Skip to main content
Premium Trial:

Request an Annual Quote

Techcomp to Distribute Ciphergen Products in China, Southeast Asia; Firms Pen Product-Development Alliance

NEW YORK, Jan. 17 (GenomeWeb News) - Ciphergen has signed a distribution and marketing agreement with Shanghai, China-based Techcomp, Ciphergen said today.


Under the terms of the agreement, Techcomp will distribute Ciphergen's ProteinChip family of products in China (excluding Taiwan), Hong Kong, Singapore, Malaysia, Vietnam, and Indonesia.


In addition, Ciphergen and Techcomp have entered into a product development and manufacturing agreement for sample preparation technology and "an associated device." The resulting product would be manufactured by Techcomp and sold by Ciphergen worldwide, Ciphergen said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.